Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Triprolidine hydrochloride monohydrate
Cat. No.:
OB0225LY-0162
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR and LC-MS.
Size:
Product Overview
Description:
Triprolidine hydrochloride monohydrate is an antihistamine that acts additionally on H1 receptors and is mainly used to relieve allergy symptoms.
Synonym:
Triprolidine hydrochloride; 6138-79-0; Triprolidine hydrochloride anhydrous; trans-Triprolidine hydrochloride; (E)-2-(3-(Pyrrolidin-1-yl)-1-(p-tolyl)prop-1-en-1-yl)pyridine hydrochloride; trans-2-(3-(1-Pyrrolidinyl)-1-p-tolylpropenyl)pyridine monohydrochloride; (E)-2-[3-(1-Pyrrolidinyl)-1-p-tolylpropenyl]pyridine hydrochloride; Pyridine, 2-(3-(1-pyrrolidinyl)-1-p-tolylpropenyl)-, monohydrochloride
CAS No.:
6138-79-0
Compound CID:
5702129
Formula:
C19H25ClN2O
Formula Weight:
332.87
Specification
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Triprolidine hydrochloride monohydrate can be used to study the efficacy of anti-allergic drugs or play an important role in exploring anti-allergic mechanisms.
Library Information
Targets:
Histamine receptor family
Receptors:
H1 receptor
Pathways:
Immunology/Inflammation; GPCR/G protein; Neuronal signaling
Plate Number:
AOCL-3
Plate Location:
a5
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
47.83 mg/mL; 143.68 mM
